illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. ShockWave Medical
Company logo

ShockWave Medical | Sustainability Performance

https://shockwavemedical.com
Linkedin

Develops medical devices for cardiovascular applications, specializing in intravascular lithotripsy for treating arterial diseases.

2009

United States

1,001 - 5,000 employees

Medical Device

$500M - 1B in revenue

$25M - 100M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#5798
Overall
#1248
in United States
#90
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Environmental
Energy consumption
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies

Company logo
Arcturus Therapeutics

United States, Hospital & Health Care, Biotechnology

Company logo
NeueHealth

United States, Hospital & Health Care, Hospital & Health Care

Company logo
Envista

United States, Hospital & Health Care, Medical Device

Renewable energy

100% 2022
Leading

Market cap

12.8B $, 2024

Revenue

730.0M $, 2023▲33% YoY

R&D intensity

19.86% 2023

Renewable electricity

Reveal data for 1 credit
100%2022

Industry rank: 2 out of 175

Total electricity consumption
and % renewables
(MWh, % of consumption)

Industry rank: 2 out of 175

Total electricity

Share of renewable electricity

Industry benchmark

Powered by illuminem and GIST Impact

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Shiseido faced criticism for cosmetic animal testing practices.
Powered by illuminem

Market cap

12.8B $, 2024▼NaN% YoY

Revenue

730.0M $, FY2023▲33% YoY

EBITDA

165.0M $, FY2023▼9.1% YoY

Operating margin

23% Industry: -136▼11.5% YoY

Revenue & EBITDA

$730.0MFY2023 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Revenue by region

Revenue by region %

All other countries
Europe
United States

Powered by illuminem

Margin trends

Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

165.5M 2023▲44% YoY

Capex

30.0M 2023▲16.7% YoY

Debt/equity ratio

1.1 Industry: 1▼NaN% YoY

R&D intensity

19.9%FY2023

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

11.0%FY2026
Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals

Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.2

▲ 3.8%

2021

0.5

▲ 0.2%

2022

0.7

▲ 0.4%

2023

2.2

2029

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

58%
Independent Directors

7 out of 12 incl. management

Powered by illuminem

Overall score

44

Environment

9

Social

54

Governance

67

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available

Sustainability employees

Total sustainability employees

4-6

    Available in
    Scale package

    Access
  • Email
  • Email